免疫血栓标志物:从机制研究向临床转化的现状与挑战
Immunothrombosis biomarkers: current status and challenges in translation from mechanistic research to clinical practice
摘要
免疫血栓是连接固有免疫与凝血反应的重要病理生理过程,相关标志物在血栓性疾病的早期识别、风险分层、疗效监测及精准干预中具有广阔的应用前景。然而,现有标志物的临床转化仍面临生物学定义不统一、标本前处理影响因素过多、检测方法缺乏标准化及结果解释不一致等挑战。为此,应明确相关标志物检验方法的金标准,并建立标准化的检测流程和质量控制体系,推动免疫血栓标志物由机制研究向临床实践转化。
Immunothrombosis is a pathophysiological process that links innate immunity with coagulation. Biomarkers of immunothrombosis show considerable promise for the early detection, risk stratification, monitoring of treatment response, and individualized management of thrombotic diseases. However, their clinical translation is hindered by inconsistent biological definitions, substantial preanalytical variation, a lack of standardized assays, and inconsistent interpretation of results. To address these challenges, appropriate reference methods for biomarker measurement should be established, together with standardized analytical procedures and robust quality control systems. These measures are essential to advance immunothrombosis biomarkers from mechanism research to clinical implementation.
年,卷(期):
2026, 49(10)
在线出版日期:
2026年10月19日